PsychoGenics Inc.
PrivateLast Round
Grant
Aug 28, 2024
Total Funding Raised
$4M
Company Overview
PsychoGenics Inc. is a biotechnology company that operates as a preclinical contract research organization (CRO) providing services for central nervous system (CNS) and orphan disorders.
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PsychoGenics Inc. Comps
Public and private peers based on sector, stage, and business model.
PsychoGenics Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Aug 28, 2024 | ||||
| Grant | Sep 5, 2023 |
Key People
Founding team and executive leadership
PsychoGenics Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute of Mental Health | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 10, 2025
Monthly visitors increased 551% MoM to 16.5K.
- Mar 24, 2025
Grew 28% QoQ, from 143 to 183 employees.
PsychoGenics Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about PsychoGenics Inc.'s valuation, stock price, and market status.
